Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT07423663

Antimicrobial Effect of Calcium Silicate and Pectin as Intracanal Medications in Necrotic Teeth With Periapical Lesions

Antimicrobial Effect of Calcium Silicate and Pectin as Intracanal Medications in Necrotic Teeth With Periapical Lesions :A Randomized Controlled Clinical Trial

Status
Active Not Recruiting
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
63 (actual)
Sponsor
Suez Canal University · Academic / Other
Sex
All
Age
21 Years – 49 Years
Healthy volunteers
Accepted

Summary

It is tackling antimicrobial resistance in endodontics, specifically comparing different intracanal medications used in root canal treatment. Given the growing concern over resistant bacterial strains, our study aims to evaluate the effectiveness of various medicaments in eliminating endodontic pathogens while minimising the risk of resistance development. By integrating microbiological analysis and clinical relevance, our research seeks to provide evidence-based recommendations for optimising intracanal disinfection protocols and improving treatment outcomes in endodontic infections.

Conditions

Interventions

TypeNameDescription
DRUGCalcium Hydroxide Intracanal medicationPatients receiving CaOH (Metapaste) intracanal medication
DRUGCalcium silicate based intracanal medicationPatients receiving Calcium silicate based (Bio-C Temp) intracanal medication
DRUGPectinPatients receiving Pectin intracanal medication

Timeline

Start date
2024-09-01
Primary completion
2026-03-10
Completion
2026-04-01
First posted
2026-02-20
Last updated
2026-02-20

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07423663. Inclusion in this directory is not an endorsement.